ConductScience.org, home

Paper10408384

C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model.

Fiane AE and 5 others. Immunopharmacology, 1999. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model. Papers, record 10408384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10408384

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model.
PubMed
Journal
Immunopharmacology
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2019-09-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fiane AEA E
2Videm VV
3Johansen HTH T
4Mellbye OJO J
5Nielsen EWE W
6Mollnes TET E

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C1 Inactivator ProteinsMajor topic
Complement Pathway, ClassicalMajor topic
Graft RejectionMajor topic
Kidney TransplantationMajor topic
LeukocytesMajor topic
Platelet ActivationMajor topic
Transplantation, HeterologousMajor topic
Animals
Antigens
Complement C1
Complement C3b
Female
Graft Survival
Humans
Immunoblotting
Immunohistochemistry
Kidney
Kininogens
Lymphocyte Activation
Male
Neutrophil Activation
Perfusion
Prekallikrein
Swine

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
40589132Immunosuppressive and Non-Immunosuppressive Drugs for Heart Xenotransplantation in Humans: Is Europe Ready?Xenotransplantation2025https://conductscience.org/library/papers/40589132PubMed
37548030Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?Xenotransplantation2023https://conductscience.org/library/papers/37548030PubMed
32155167Normothermic machine perfusion of ischaemically damaged porcine kidneys with autologous, allogeneic porcine and human red blood cells.PLoS One2020https://conductscience.org/library/papers/32155167PubMed
30882931Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits.Glia2019https://conductscience.org/library/papers/30882931PubMed
29935708Innate networking: Thrombotic microangiopathy, the activation of coagulation and complement in the sensitized kidney transplant recipient.Transplant Rev (Orlando)2018https://conductscience.org/library/papers/29935708PubMed
27554374Generation of α-1,3-galactosyltransferase knocked-out transgenic cloned pigs with knocked-in five human genes.Transgenic Res2017https://conductscience.org/library/papers/27554374PubMed
27500225Kidneys From α1,3-Galactosyltransferase Knockout/Human Heme Oxygenase-1/Human A20 Transgenic Pigs Are Protected From Rejection During Ex Vivo Perfusion With Human Blood.Transplant Direct2015https://conductscience.org/library/papers/27500225PubMed
25249935C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammation.Front Cell Neurosci2014https://conductscience.org/library/papers/25249935PubMed
21496117Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection.Xenotransplantation2011https://conductscience.org/library/papers/21496117PubMed
21345278Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses.Crit Care2011https://conductscience.org/library/papers/21345278PubMed
19710096Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity.Innate Immun2010https://conductscience.org/library/papers/19710096PubMed
19376229Antibody-mediated xenograft injury: mechanisms and protective strategies.Transpl Immunol2009https://conductscience.org/library/papers/19376229PubMed
18674818Biological activities of C1 inhibitor.Mol Immunol2008https://conductscience.org/library/papers/18674818PubMed
17544816C1 inhibitor: biologic activities that are independent of protease inhibition.Immunobiology2007https://conductscience.org/library/papers/17544816PubMed
11737055Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver.Clin Exp Immunol2001https://conductscience.org/library/papers/11737055PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SERPING1710PubTator's text mininghttps://conductscience.org/library/genes/710

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10408384

GET https://conductscience.org/api/papers/v1/10408384/authors